Back to explore
The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties
2 Assessments
0 Serious · 2 Some · 0 No · 0 N/A
| Reviewer | Date | Q1.1Does the study have an associated retraction? | Q1.2Does the study have an associated expression of concern or other relevant post-publication notice? | Q1.3Do other studies by the research team highlight causes for concern? | Q2.2Are there concerns relating to the timing or absence of study registration? | Overall | Actions |
|---|---|---|---|---|---|---|---|
| RV009 Systematic reviewer | 12 Nov 2025 | No | No | No | Unclear | Some concerns | View |
| RV003 Research Fellow | 31 Oct 2025 | No | No | No | Unclear | Some concerns | View |
Publication Details
Journal
European Journal of Drug Metabolism and Pharmacokinetics
Publisher
Springer Science and Business Media LLC
Published
5 Dec 2014
Pages
pp. 139–147
ISSN / eISSN
0378-7966 / 2107-0180